6Boessen R, Groenwold RH, Knol M J, et al. Comparing HAMD (17) and HAMD subscales on their ability to dif- ferentiate active treatment from placebo in randomized controlled trials[J]. JAffect Disord, 2013,145( 3 ) : 363. 被引量：1
8Schutters SI, van Megen H J, Van Veen JF, et al. Parox- etine augmentation in patients with generalised social anx- iety disorder, non-responsive to mirtazapine or placebo [J]. Hum Psychopharmacol, 2011,26( 1 ) : 72. 被引量：1
9Kim JE, Yoon S J, Kim J, et al. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomized par- oxetine controlled trial[J]. Int J Clin Pract, 2011,65 (3) : 323. 被引量：1
